【24h】

LAP-Banding Obesity: A Case of Stomach Perforation, Peritonitis, and Death.

机译:LAP带状肥胖:胃穿孔,腹膜炎和死亡的情况。

获取原文
获取原文并翻译 | 示例
           

摘要

We present a case of peritonitis and death due to the misplacement of a laparoscopic adjustable band inserted through, instead of around, the stomach. This represents the first case in the published literature where a LAP-BAND perforated the stomach, followed by peritonitis and death. The morbidly obese female patient with a history of hypertension and arthritis was 47 years old, 5 feet 6 inches tall, weighed 361 pounds, and had a body mass index of 58.3. She underwent a 2-hour, elective, LAP-band insertion operation to achieve weight loss; 27 hours after band insertion, following the conduction of all FDA-mandated Lap-Band postoperative protocol (including a radiologic Gastrogrografin swallow), the patient was discharged with "no evidence of esophageal stasis or obstruction." She remained out of hospital care and in her residence until she called for and was taken by an ambulance to an alternate, local hospital (57 hours after band insertion), when gastric perforation was confirmed via x-ray and CT scans. No open surgery was attempted to repair the damage, and cardiac arrest ensued 7 hours after admission to the second hospital. The patient was pronounced dead 64 hours after LAP-band insertion. This unique case is significant, given that there were no deaths of this kind reported in The LAP-BAND(R) Adjustable Gastric Banding System Summary of Safety and Effectiveness Data by the United States Center for Devices and Radiologic Health, of the Food and Drug Administration, or in searches of the published literature.
机译:由于腹腔镜可调节带通过胃而不是胃周围插入而引起的腹膜炎和死亡,我们呈现出腹膜炎和死亡的情况。这代表了已发表文献中的第一个案例,其中有一个LAP-BAND穿孔在胃中,随后是腹膜炎和死亡。这位有高血压和关节炎病史的病态肥胖女性患者,现年47岁,高5英尺6英寸,体重361磅,体重指数为58.3。她进行了2小时的选择性LAP乐队插入手术,以达到减肥的目的。束带插入后27小时,在完成所有FDA规定的Lap-Band术后规程(包括放射性Gastrogrografin吞咽)后,患者出院,“没有食道淤血或阻塞的证据”。她一直没有住院治疗,一直待在她的住所中,直到她打电话要求并被一辆救护车带到另一家当地医院(插入带子后57小时),当时通过X射线和CT扫描证实了胃穿孔。没有尝试进行开放性手术来修复损伤,入院第二小时后出现了心脏骤停。 LAP频段插入后64小时,该患者被宣布死亡。鉴于美国食品和药品管理局器械与放射卫生中心在LAP-BAND(R)可调胃束带系统安全性和有效性数据摘要中没有报告此类死亡,这一独特案例意义重大。管理,或搜索公开的文献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号